[Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)].
Oral candidiasis is a frequent opportunistic infection in AIDS patients. High risk of dissemination and frequent relapses are common. The autors in Dakar at the Infectious Diseases Department Fann Hospital conduct an open non randomized trial with Fluconazole for the treatment of oral candidiasis in HIV seropositive patients. They find a clinical efficacy of 84.14% a biological efficacy of 63.3% and a good excellent tolerance (100%). But, the high price of this product limits its utilisation in developing countries.
Sow
P S
PS
Service des Maladies Infectieuses, CHU de Fann, Dakar.
Diop
B M
BM
Ndiaye
I
I
Faye
M A
MA
Coll-Seck
A M
AM
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D002177:Candidiasis / Q000188:drug therapy*; D002180:Candidiasis, Oral / Q000188:drug therapy*; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010608:Pharyngeal Diseases / Q000188:drug therapy*; D011446:Prospective Studies; D012675:Senegal
D015725:Fluconazole
Le fluconazole dans les candidoses bucco-pharyngées au cours de l'infection rétrovirale (expérience dakaroise).